Predictors of Total Occlusion of the Culprit Artery in Low-to-Intermediate Risk NSTEMI-ACS: A Retrospective Study

Abstract

Introduction: In patients with low-to-intermediate risk acute non-ST-elevation myocardial infarction–acute coronary syndrome (NSTEMI-ACS), non-invasive treatments have gained importance. However, these patients may present with a wide spectrum, ranging from microvascular involvement to partial or complete epicardial artery occlusion. Patients with total occlusion of the culprit artery have higher morbidity and mortality rates. Early invasive treatment may reduce these rates. Therefore, early identification of such patients is important. Nonetheless, no specific clinical or laboratory distinguishing factors have been identified. This study aimed to investigate the role of inflammatory markers in identifying patients with total occlusion of the culprit artery among those with low-to-intermediate risk NSTEMI-ACS. Patients and Methods: This retrospective cohort study included patients diagnosed with NSTEMI-ACS who underwent coronary angiography in a tertiary cardiology clinic between January 2018 and December 2019. A total of 276 patients were enrolled, while 32 meeting exclusion criteria were excluded. The remaining patients were classified as those with total occlusion of the culprit artery (n=47) and those without (n=229). Inflammatory markers were compared between groups. Results: Statistically significant differences were found between the groups in terms of neutrophil-to-lymphocyte ratio (NLR) (p=0.01), systemic immune-inflammation index (SII) (p=0.016), and mean platelet volume (MPV) (p=0.028). Conclusion: According to the findings of this study, NLR, SII, and MPV may be useful in determining the presence of total occlusion of the culprit artery in NSTEMI-ACS patients. However, the causal relationship between these parameters and total occlusion remains unclear. Larger, multicenter studies are required to confirm their predictive value and determine the ideal cutoff points.

Keywords

• Non-ST-elevation myocardial infarction
• total occlusion
• neutrophil-to-lymphocyte ratio
• systemic immune-inflammation index
• mean platelet volume

Düşük-orta riskli NSTEMI'de Sorumlu Arterin Total Oklüde Olmasını Belirlemede ki Öngörücüler: Retrospektif Bir Çalışma

Abstract

Giriş: Düşük-orta riskli Akut ST-non-elevasyonsuz miyokard infarktüsü-akut koroner sendromlu (NSTEMI-ACS) hastalarda non-invaziv tedaviler önem kazanmaktadır. Ancak düşük-orta riskli NSTEMI-AKS hastaları mikrovasküler tutulumdan parsiyel veya total epikardiyal arter tıkanıklığına kadar değişen bir tablo ile karşımıza çıkabilmektedir. Sorumlu arterinde total obstrüksiyonu olan hastaları artmış morbidite ve mortalite oranlarına sahiptir. Bu hastalarda erken invazif tedavi bu oranların düşürülmesinde etkili olabilir. Dolayısıyla bu hastaların erken dönemde ayırt edilmesi önemli olabilir. Bununla birlikte bu hastaları ayırt edici klinik veya laboratuvar ayırt edici faktör bulunmamaktadır. Bu çalışmada düşük-orta riskli NSTEMI-AKS hastalarda sorumlu arteri total obstrüksiyonu olan hastaları ayırt etmede inflamatuar belirteçlerin rolü araştırıldı. Hastalar ve Yöntem: Retrospektif kohort çalışması olarak tasarlanan çalışmaya Ocak 2018-Aralık 2019 tarihleri arasında üçüncü basamak kardiyoloji kliniğinde NSTEMI-AKS tanısı ile koroner anjiyografi yapılan hastalar dahil edilmiştir. Bu hastaları (n= 276), dışlama kriterleri olan hastalar (n= 32) ekarte edildi. Sonuç olarak sorumlu arteri total oklüzyon olan (n= 47) ve total oklüzyonu olmayan (n= 229) olarak gruplandırılmıştır. İnflamatuvar göstergeler bu gruplar arasında kıyaslanmıştır. Bulgular: Nötrofil lenfosit oranı (NLR) (p= 0.01), sistemik immün inflamasyon indeksi (SII) (p= 0.016) ve ortalama trombosit hacmi (MPV) (p= 0.028) parametleri ile NSTEMI-AKS hastalarında sorumlu arterde total tıkanıklığı olan ve olmayan gruplar arasında istatistiksel olarak fark olduğu saptanmıştır. Sonuç: Bu çalışma sonucunda elde edilen bulgulara göre NLR, SII ve MPV parametrelerinin NSTEMI -AKS hastalarında sorumlu arterin total tıkalı olup olmamasının tespitinde faydalı olabilir. Bu sonucun total tıkanıklık ile neden-sonuç ilişkisi net değildir. Bu parametrelerin öngörücü değerleri ve ideal kesme noktasının tespiti için çok merkezli ve büyük ölçekli araştırmaları gerektirmektedir.

Keywords

• ST yükselmesiz miyokart infarktüsü
• total oklüzyon
• nötrofil lenfosit oranı
• sistemik immün inflamasyon indeksi
• ortalama trombosit hacmi

References

1. ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal: Acute Cardiovascular Care, 2024;13(1), 55-161. [Crossref]
2. 2.Sabatine MS, Morrow DA, Cannon CP, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. J Am Coll Cardiol. 2002;40(10):1761-8. [Crossref]
3. 3.Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470-6. [Crossref]
4. 4.Sansanayudh N, Anothaisintawee T, Muntham D, McEvoy M, Attia J, Thakkinstian A. Mean platelet volume and coronary artery disease: a systematic review and meta-analysis. Int J Cardiol. 2014 Aug 20;175(3):433-40. doi: 10.1016/j.ijcard.2014.06.028. Epub 2014 Jun 28. Erratum in: Int J Cardiol. 2014;177(3):1145. [Crossref]
5. 5.Isik T, Uyarel H, Tanboga IH, Kurt M, Ekinci M, Kaya A, et al. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Coron Artery Dis. 2012;23(1):51-6. [Crossref]
6. 6.Temiz A, Gazi E, Güngör Ö, Barutçu A, Altun B, Bekler A, et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit. 2014;20:660-5. [Crossref]
7. 7.Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzut M, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 2012;225:456-60. [Crossref]
8. 8.Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest 2020;50:e13230. [Crossref]

9. 9.Tang EW, Wong CK, Herbison P. Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts longterm mortality post acute coronary syndrome. Am Heart J 2007;153:29-35. [Crossref]
10. 10.Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immuneinflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res 2014;20:6212-22. [Crossref]
11. 11.Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983;51:606. [Crossref]
12. 12.Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. [Crossref]
13. 13.Sheridan SL, Viera AJ, Krantz MJ, Ice CL, Steinman LE, Peters KE, et al. The effect of giving global coronary risk information to adults: a systematic review. Archives of internal medicine 2010;170(3), 230-9. [Crossref]
14. 14.Sugiyama T, Hasegawa K, Kobayashi Y, Takahashi O, Fukui T, Tsugawa Y. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011. Journal of the American Heart Association, 2015;4(3), e001445. [Crossref]
15. 15.McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. The American journal of medicine, 2011;124(1), 40-7. [Crossref]
16. 16.Almendro-Delia M, Seoane García T, Villar Calle P, García González N, Lorenzo López B, Cortés FJ, et al. Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes. Int J Cardiol. 2020;S0167-5273(20)33821-3.
17. 17.Khan AR, Golwala H, Tripathi A, Bin Abdulhak AA, Bavishi C, Riaz H, et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2017;38(41):3082-9. [Crossref]
18. 18.Hung CS, Chen YH, Huang CC, Lin MS, Yeh CF, Li H.Y., et al. Prevalence and outcome of patients with non-ST segment elevation myocardial infarction with occluded "culprit" artery - a systemic review and meta-analysis, Crit. Care 2018;22(1):1-11. [Crossref]
19. 19.Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med 2013;368:2004-13. [Crossref]
20. 20.Madjid M, Fatemi O. Components of the complete blood count as risk predictors for coronary heart disease: in-depth review and update. Tex Heart Inst J. 2013;40(1):17-29.
21. 21.Murat SN, Duran M, Kalay N, Gunebakmaz O, Akpek M, Doger C, et al. Relation between mean platelet volume and severity of atherosclerosis in patients with acute coronary syndromes. Angiology. 2013;64(2):131-6. [Crossref]
22. 22.Vogiatzis I, Samaras A, Grigoriadis S, Sdogkos E, Koutsampasopoulos K, Bostanitis I. The Mean Platelet Volume in the Prognosis of Coronary Artery Disease Severity and Risk Stratification of Acute Coronary Syndromes. Med Arch. 2019;73(2):76-80. [Crossref]
23. 23.Spark JI, Sarveswaran J, Blest N, Charalabidis P, Asthana S. An elevated neutrophil-lymphocyte ratio independently predicts mortality in chronic critical limb ischemia. J Vasc Surg. 2010;52(3): 632-6. [Crossref]
24. 24.Bian C, Wu Y, Shi Y, Xu G, Wang J, Xiang M, et al. Predictive value of the relative lymphocyte count in coronary heart disease. Heart Vessels. 2010;25(6):469-73. [Crossref]
25. 25.Uysal HB, Dağlı B, Akgüllü C, Avcil M, Zencir C, Ayhan M, et al. Blood count parameters can predict the severity of coronary artery disease. Korean J Intern Med. 2016;31(6):1093-100. [Crossref]